New bill aims to promote breast cancer risk assessment tools

The Know Your Risk Act is new federal legislation introduced by Senator Mark Kelly and actress Olivia Munn that aims to promote the use of validated breast cancer risk assessment tools and create a single, comprehensive screening tool accessible to all patients and providers.

  • Sen. Mark Kelly (D-AZ) and breast cancer survivor Olivia Munn introduced the bipartisan Know Your Risk Act (H.R. 10763) on November 18
  • The bill addresses an estimated 382,640 U.S. breast cancer diagnoses expected in 2026, with about 85% of patients having no family history
  • Currently, no single, widely recognized risk assessment tool exists despite options like the Gail Model, Tyrer-Cuzick, and FDA-authorized AI mammogram tools
  • If enacted, the HHS must report within 180 days on tool inaccuracies, gaps in use across populations, and plans for a comprehensive public tool
  • The bill amends screening grant programs to support provider training, electronic health record integration, public education, and research to improve accuracy across diverse patient groups

Newly introduced federal legislation aims to promote the use of validated breast cancer risk assessment tools, and the bill has celebrity endorsement.

Sen. Mark Kelly (D-AZ) and actress and breast cancer survivor Olivia Munn introduced the bipartisan Know Your Risk Act (H.R. 10763) on November 18 in a press conference.  

“We have an opportunity to shift some of the responsibility away from women having to know every question, every risk factor to research, and every step to advocate for themselves, and put more of that responsibility where it belongs – to the medical professionals caring for them,” Munn said during the press conference. 

The bill cites an estimated 382,640 U.S. breast cancer diagnoses in 2026 and says about 85% of patients have no family history. It also says no single, widely recognized risk assessment tool exists, despite options like the Gail Model, Tyrer-Cuzick, and a 2025 AI mammogram risk tool authorized by the U.S. Food and Drug Administration (FDA). 

Should the bill be enacted, the U.S. Department of Health & Human Services (HHS) will be required within 180 days to report inaccuracies in existing tools, gaps in their use across populations, and contributing factors. The report must also outline planning for a single, comprehensive, publicly accessible tool, with strategies for public awareness and for building consensus among patients, providers, universities, and other stakeholders. 

The bill also amends the Public Health Service Act’s screening grant program to support evidence-based risk assessments, provider training on validated models, standardized tools integrated into electronic health records, public education, and research to improve model accuracy across patient groups. State grantees would report how many people were assessed, how many were identified as elevated risk, referrals made, and access disparities. 

Susan G. Komen voiced support for the bill, with President and CEO Amber Guild saying people who understand their breast cancer risk early can begin screening sooner, advocate for the care they need, and catch this disease when it is most survivable.  

“The Know Your Risk Act puts that power where it belongs, in people’s own hands, and it moves us toward the goal at the heart of our mission: finding breast cancer earlier, for everyone,” said Guild in a prepared statement. “We thank Senator Kelly for his leadership, and we will not rest until no one dies from breast cancer.”

Page 1 of 585
Next Page